Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3UBA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $61,132
Award facts
- Contract value 100% obligated
- $61,131.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $61K to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injections on January 21, 2026. This firm fixed-price, non-set-aside contract is scheduled for completion by January 22, 2026, with performance occurring at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc. (doing business as AmerisourceBergen), which holds a substantial $1 billion indefinite delivery contract with DLA Troop Support Medical through December 2031, serving as the primary vehicle for supplying pharmaceuticals and medical supplies to military healthcare systems globally.
AmerisourceBergen is a major pharmaceutical distributor that consistently wins competitive federal contracts to supply a broad range of medications and medical commodities to defense and veteran healthcare programs. This specific award for Dupixent, a specialty pharmaceutical used to treat conditions such as atopic dermatitis and asthma, reflects the company's ongoing role as a critical vendor within the federal medical supply chain. The non-set-aside status and firm fixed-price structure are consistent with AmerisourceBergen's typical federal contracting approach, demonstrating its capability to meet government pharmaceutical procurement requirements through open competition.
Quick answers
Who was awarded contract SPE2DR26F3UBA?
SPE2DR26F3UBA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F3UBA worth?
The government has obligated $61,132 on SPE2DR26F3UBA.
Is contract SPE2DR26F3UBA an order under another contract?
Yes. SPE2DR26F3UBA is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3UBA competed?
The extent of competition for SPE2DR26F3UBA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award